Evidence map›Paper›PMID 36740725›Full record

ArticleEndocrinology2023

miR-223 Plays a Key Role in Obesogen-Enhanced Adipogenesis in Mesenchymal Stem Cells and in Transgenerational Obesity.

Richard C Chang, Erika M Joloya, Zhuorui Li, Bassem M Shoucri, Toshi Shioda, Bruce Blumberg

Open access · greenAbstract read
In one paragraph

Article in Endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Anti-inflammatory effects of kawakawa (Food science & nutrition · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Inherited Epigenetic Hallmarks of Childhood Obesity Derived from Prenatal Exposure to Obesogens.International journal of environmental research and public health · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Richard C ChangDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697-2300, USA.ORCID 0000-0003-3235-1959
Erika M JoloyaDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697-2300, USA.
Zhuorui LiDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697-2300, USA.
Bassem M ShoucriDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697-2300, USA.
Toshi ShiodaCenter for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129, USA.ORCID 0000-0002-9434-7835
Bruce BlumbergDepartment of Developmental and Cell Biology, University of California, Irvine, CA 92697-2300, USA.ORCID 0000-0002-8016-8414
University of California, Irvine · USMassachusetts General Hospital · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
Transgenerational obesity caused by ancestral exposure to obesogens in utero: changes in germline genomic architecture, roles of gonadal somatic cells, and metabolomic analysis of sexual dimorphismR01ES023316 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BRUCE BLUMBERG, TOSHIHIRO SHIODA · 2013 to 2026
$8.3M
Interactions between prenatal obesogen exposure and Total Western diet lead to a transgenerational thrifty phenotype: functional and epigenomic analysis of effects in fat and liverR01ES031139 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLUMBERG, BRUCE, SHIODA, TOSHIHIRO · 2020 to 2025
$2.4M
Applications of the long-term culture human primordial germ cell-like cells to toxicological assessments and mechanistic studies on chemically caused heritable human health threatsR21ES034468 · NIEHS · MASSACHUSETTS GENERAL HOSPITAL · PI SHIODA, TOSHIHIRO · 2023 to 2024
$459k
EPA FP917800NCI NIH HHS P30 CA062203NIEHS NIH HHS R01 ES023316NIEHS NIH HHS R01 ES031139NIEHS NIH HHS R21 ES034468
6 · The paper itself

Abstract

Exposure of pregnant F0 mouse dams to the obesogen tributyltin (TBT) predisposes unexposed male descendants to obesity and diverts mesenchymal stem cells (MSCs) toward the adipocytic lineage. TBT promotes adipogenic commitment and differentiation of MSCs in vitro. To identify TBT-induced factors predisposing MSCs toward the adipocytic fate, we exposed mouse MSCs to TBT, the peroxisome proliferator activated receptor gamma (PPARγ)-selective agonist rosiglitazone, or the retinoid X receptor (RXR)-selective agonist LG-100268. Then we determined their transcriptomal profiles to determine candidate microRNAs (miR) regulating adipogenic commitment and differentiation. Of the top 10 candidate microRNAs predicted by Ingenuity Pathway Analysis, miR-21, miR-33, and miR-223 were expressed consistent with an ability to differentially regulate target genes during adipogenesis. We found that 24-hour exposure to 50nM TBT caused miR-223 levels in MSCs to increase; expression of its target genes ZEB1, NFIB, and FOXP1 was decreased. Rosiglitazone and TBT increased miR-223 levels. This induction was inhibited by the PPARγ antagonist T0070907 but not by the RXR antagonists HX531 or UVI3003, placing miR-223 downstream of PPARγ. Chromatin immunoprecipitation confirmed TBT-induced binding of PPARγ to regulatory elements in the miR-223 promoter. miR-223 levels were elevated in white adipose tissue of F2 and F3 male descendants of pregnant F0 mouse dams exposed to 50nM TBT throughout gestation. miR-223 levels were potentiated in males fed an increased fat diet. We infer that TBT induced miR-223 expression and increased adipogenesis in MSCs through the PPARγ pathway and that transgenerationally increased expression of miR-223 plays an important role in the development of obesity caused by TBT exposure.

Indexed as

Mesenchymal Stem CellsMicroRNAsAdipogenesisAnimalsCell DifferentiationFemaleMaleMiceObesityPPAR gammaPregnancyRosiglitazoneTrialkyltin CompoundsMicroRNAsMIRN223 microRNA, mouseMirn33 microRNA, mousePPAR gammaRosiglitazoneTrialkyltin CompoundstributyltinadipogenesisEDCendocrine disruptormicroRNAMSCobesityPPARgammaRXRtransgenerational

Identifiers

PMID36740725
PMCPMC10282922
OpenAlexW4319294769

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.